Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Margaret E. Gerbasi"'
Autor:
Margaret E. Gerbasi, Shruti Nambiar, Spencer Reed, Kalin Hennegan, Nandini Hadker, Adi Eldar-Lissai, Stephanie Cosentino
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundEssential tremor (ET) is among the most common movement disorders in adults. While ET is diagnosed and primarily characterized by the presence of tremor, it also can impact cognition, sleep, mood, and motor functioning more broadly. The man
Externí odkaz:
https://doaj.org/article/694ba5ad3a81435bb6522509b2e1946e
Autor:
Rupinder K. Legha, Margaret E. Gerbasi, Mary C. Smith Fawzi, Eddy Eustache, Tatiana Therosme, J. Reginald Fils-Aime, Giuseppe J. Raviola, Emmeline Affricot, Ermaze Louis Pierre, Yoldie Alcindor, Jennifer Severe, Katherine A. Boyd, David J. Grelotti, Sarah Darghouth, Andrew Rasmussen, Anne E. Becker
Publikováno v:
Conflict and Health, Vol 14, Iss 1, Pp 1-9 (2020)
Abstract Background The Zanmi Lasante Depression Symptom Inventory (ZLDSI) is a screening tool for major depression used in 12 primary care clinics in Haiti’s Central Plateau. Although previously validated in a clinic-based sample, the present stud
Externí odkaz:
https://doaj.org/article/b8fc3690aaf9428eba63bd6be91de445
Autor:
Jean-Louis Vincent, Nathan D. Nielsen, Nathan I. Shapiro, Margaret E. Gerbasi, Aaron Grossman, Robin Doroff, Feng Zeng, Paul J. Young, James A. Russell
Publikováno v:
Annals of Intensive Care, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract Background Maintenance of mean arterial pressure (MAP) at levels sufficient to avoid tissue hypoperfusion is a key tenet in the management of distributive shock. We hypothesized that patients with distributive shock sometimes have a MAP belo
Externí odkaz:
https://doaj.org/article/a605c7bf8e1e41abbb7919fecb29f3b9
Autor:
Ming-Yi Huang, Samantha Meltzer-Brody, Moshe Fridman, Sarah Acaster, Vijayveer Bonthapally, Stephen Kanes, Mark Kosinski, Margaret E. Gerbasi, Adi Eldar-Lissai, Paul Hodgkins
Publikováno v:
Current Medical Research and Opinion. 37:1221-1231
To evaluate the health-related quality of life (HRQoL) burden associated with postpartum depression (PPD), determine the extent to which clinical response impacts HRQoL, and estimate the impact of PPD and clinical response on healthcare resource util
Autor:
Moshe Fridman, Stephen Kanes, Margaret E. Gerbasi, Paul Hodgkins, Vijayveer Bonthapally, Sarah Acaster, Samantha Meltzer-Brody, Adi Eldar-Lissai
Publikováno v:
Journal of Women's Health. 30:385-392
Background: Brexanolone (BRX) injection was approved by the United States Food and Drug Administration in 2019 for the treatment of adults with postpartum depression (PPD) based on two Phase 3 clin...
Autor:
Samantha Meltzer-Brody, Paul Hodgkins, Vijayveer Bonthapally, Stephen Kanes, Moshe Fridman, Adi Eldar-Lissai, Sarah Acaster, Margaret E. Gerbasi
Publikováno v:
Archives of Women's Mental Health
The objective of this study is to explore the associations between the patient-reported Edinburgh Postnatal Depression Scale (EPDS) and Patient Health Questionnaire (PHQ)-9 and clinician-reported 17-item Hamilton Depression Rating Scale (HAMD-17) in
Autor:
Elizabeth Chertavian, Scott J. Johnson, Margaret E. Gerbasi, Paul Hodgkins, Samantha Meltzer-Brody, Julia C. Bond, Joshua T. Cohen, Adi Eldar-Lissai
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:627-638
Brexanolone injection (BRX) was approved by the FDA in 2019 for the treatment of adult patients with postpartum depression (PPD), but its cost-effectiveness has not yet been evaluated.To estimate the cost-effectiveness of BRX compared with treatment
Autor:
Dinesh Mishra, Margaret E. Gerbasi, Roy Koruth, Sameer R. Ghate, Briana Ndife, Aaron Moynahan, Daniel Stellato, P Gunda, Thomas E. Delea
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 25:1227-1237
Before the approval of dabrafenib and trametinib in combination, there were no approved therapies in the adjuvant setting that target the RAS/RAF/MEK/ERK pathway.To evaluate the budget impact of dabrafenib and trametinib in combination for adjuvant t
Autor:
Margaret E. Gerbasi, Briana Ndife, Thomas E. Delea, Aaron Moynahan, Roy Koruth, Daniel Stellato, P Gunda, Dinesh Mishra, Sameer R. Ghate
Publikováno v:
Journal of Medical Economics. 22:1243-1252
Objective The COMBI-AD trial demonstrated the efficacy and safety of dabrafenib and trametinib in combination versus placebo as adjuvant treatment of patients with BRAF V600E/K mutation-positive resected Stage IIIA (lymph node metastasis >1 mm), IIIB
Publikováno v:
Health Behavior and Policy Review. 6:242-255
Objective To investigate the association of a variety of social smoking exposures with cigarette smoking among iTaukei adolescent women in Fiji. Methods Self-report data were collected in a representative sample of school-going iTaukei adolescent wom